Brokers

Brokers Set Expectations for Bath & Body Works, Inc.’s Q1 2024 Earnings (NYSE:BBWI)


Bath & Body Works, Inc. (NYSE:BBWIGet Rating) – Stock analysts at Telsey Advisory Group issued their Q1 2024 earnings estimates for Bath & Body Works in a research report issued on Thursday, May 12th. Telsey Advisory Group analyst D. Telsey forecasts that the company will post earnings of $0.66 per share for the quarter. Telsey Advisory Group has a “Outperform” rating and a $70.00 price target on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q2 2024 earnings at $0.89 EPS.

Bath & Body Works (NYSE:BBWIGet Rating) last posted its quarterly earnings results on Wednesday, February 23rd. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. The firm had revenue of $3.03 billion during the quarter, compared to analysts’ expectations of $2.96 billion. During the same quarter in the previous year, the business earned $1.96 earnings per share. The company’s revenue was up 11.4% on a year-over-year basis.

BBWI has been the subject of several other research reports. Zacks Investment Research cut Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Monday, May 9th. Wells Fargo & Company decreased their price target on Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating for the company in a research note on Tuesday, April 5th. The Goldman Sachs Group upgraded Bath & Body Works from a “buy” rating to a “conviction-buy” rating in a research report on Wednesday, January 19th. JPMorgan Chase & Co. reduced their price objective on Bath & Body Works from $105.00 to $81.00 and set an “overweight” rating for the company in a research report on Thursday, February 24th. Finally, Credit Suisse Group reduced their price objective on Bath & Body Works from $69.00 to $64.00 and set a “neutral” rating for the company in a research report on Friday, February 25th. Three investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $78.63.

BBWI stock opened at $51.01 on Monday. Bath & Body Works has a 1-year low of $44.17 and a 1-year high of $82.00. The business has a fifty day moving average price of $50.34 and a 200-day moving average price of $59.58. The stock has a market capitalization of $12.17 billion, a P/E ratio of 10.37, a P/E/G ratio of 1.13 and a beta of 1.56.

In other news, CFO Wendy C. Arlin sold 6,000 shares of the company’s stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total value of $330,000.00. Following the completion of the transaction, the chief financial officer now owns 98,888 shares of the company’s stock, valued at $5,438,840. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Prospera Financial Services Inc bought a new position in shares of Bath & Body Works in the first quarter worth about $25,000. Northwestern Mutual Wealth Management Co. boosted its stake in Bath & Body Works by 119.7% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 525 shares of the company’s stock valued at $26,000 after buying an additional 286 shares during the last quarter. Acadian Asset Management LLC bought a new position in Bath & Body Works during the fourth quarter valued at approximately $30,000. First Horizon Advisors Inc. boosted its stake in Bath & Body Works by 361.4% during the first quarter. First Horizon Advisors Inc. now owns 646 shares of the company’s stock valued at $31,000 after buying an additional 506 shares during the last quarter. Finally, CX Institutional bought a new position in Bath & Body Works during the third quarter valued at approximately $34,000. 97.11% of the stock is owned by hedge funds and other institutional investors.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Articles

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)



Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.